220 related articles for article (PubMed ID: 2860265)
1. Displacement by alpha-adrenergic agonists and antagonists of 3H-prazosin bound to the alpha-adrenoceptors of the dog aorta and the rat brain.
Nagatoma T; Tsuchihashi H; Sasaki S; Nakagawa Y; Nakahara H; Imai S
Jpn J Pharmacol; 1985 Feb; 37(2):181-7. PubMed ID: 2860265
[TBL] [Abstract][Full Text] [Related]
2. Agonists interaction with radiolabeled alpha-adrenoceptor antagonists binding sites in rat mesenteric artery.
Agrawal DK; Daniel EE
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S66-75. PubMed ID: 2414598
[TBL] [Abstract][Full Text] [Related]
3. Identification of alpha adrenoceptor subtypes in dog arteries by (3H) yohimbine and (3H) prazosin.
Bobik A
Life Sci; 1982 Jan; 30(3):219-28. PubMed ID: 6122151
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two distinct alpha-adrenoceptor binding sites in smooth muscle cell membranes from rat and bovine aorta.
Descombes JJ; Stoclet JC
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):282-8. PubMed ID: 2862590
[TBL] [Abstract][Full Text] [Related]
5. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
Asano M; Hashimoto H; Nakashima M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
7. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
9. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
Tsuchihashi H; Nagatomo T
J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
[TBL] [Abstract][Full Text] [Related]
10. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
11. Effect of 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monophydrochloride (SGB-1534), an antihypertensive agent, on 3H-prazosin and 3H-p-aminoclonidine binding to alpha 1- and alpha 2-adrenoceptors in dog brain and aorta.
Nagatomo T; Aono J; Tajiri A; Nakamura T; Tsuchihashi H
Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1122-7. PubMed ID: 2900699
[No Abstract] [Full Text] [Related]
12. Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: competition studies with [3H]prazosin and [3H]idazoxan.
Reader TA; Brière R; Grondin L
J Neural Transm; 1987; 68(1-2):79-95. PubMed ID: 2879884
[TBL] [Abstract][Full Text] [Related]
13. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.
Greengrass P; Bremner R
Eur J Pharmacol; 1979 May; 55(3):323-6. PubMed ID: 37098
[TBL] [Abstract][Full Text] [Related]
14. 3H-Prazosin binds specifically to 'alpha 1'-adrenoceptors in rat brain.
Miach PJ; Dausse JP; Cardot A; Meyer P
Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):23-6. PubMed ID: 6248797
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of [3H]E-643-binding to alpha adrenoceptors.
Hata F; Kondo E; Kondo S; Kagawa K; Ishida H
Jpn J Pharmacol; 1982 Feb; 32(1):181-7. PubMed ID: 6123609
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle.
Muramatsu I; Ohmura T; Kigoshi S; Hashimoto S; Oshita M
Br J Pharmacol; 1990 Jan; 99(1):197-201. PubMed ID: 1970493
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of two distinct alpha 1-adrenoceptor subtypes in rabbit thoracic aorta.
Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1993 Apr; 108(4):1071-6. PubMed ID: 8097950
[TBL] [Abstract][Full Text] [Related]
18. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA
J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954
[TBL] [Abstract][Full Text] [Related]
19. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
20. The modulatory role of vascular endothelium in the interaction of agonists and antagonists with alpha-adrenoceptors in the rat aorta.
Alosachie I; Godfraind T
Br J Pharmacol; 1988 Oct; 95(2):619-29. PubMed ID: 2906562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
